As political leaders from around the world get ready to meet at the COP 28 climate conference, life science companies are taking steps to encourage sustainabili 29 November 2023
Industry lobbyist the Pharmaceutical Research and Manufacturers of America (PhRMA) has criticized greater use of prior authorization in Medicaid. 29 November 2023
A new center for the manufacturing of advanced medicines is set to be built in Scotland after a multi-million-pound fund was announced in the UK government’s Au 23 November 2023
Tense negotiations between the UK Government and the pharmaceutical industry over a new drug pricing framework have concluded with a far-reaching agreement. 20 November 2023
In a strongly-worded statement, the Hellenic Association of Pharmaceutical Companies (SFEE) has argued against mandatory rebates on drug expenditure. 13 November 2023
US pharma giant Pfizer has revealed the cost of its oral antiviral treatment for COVID-19, Paxlovid (nirmatrelvir/ritonavir), once the company starts selling th 20 October 2023
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.